Skip to main content

Utilization of Dupilumab: A Descriptive Analysis

Basic Details
Date Posted
Status
Complete
Medical Product
dupilumab
Description

In this analysis, we evaluated trends in utilization of dupilumab in the Merative™ MarketScan® Research Database. The study period included data from January 1, 2017 to September 30, 2022. This request was run against the Merative™ MarketScan® Research Database on September 15, 2023.

Deliverables (1)
Sentinel Modular Program Report: Utilization of Dupilumab: A Descriptive Analysis
Additional Details
FDA Center
CDER
Time Period
January 1, 2017 - September 30, 2022
Analysis Type
Descriptive
Population / Cohort
All individuals
Data Sources
Merative™ MarketScan® Research Databases
Related Links
Sentinel Drug Study: Dupixent (Dupilumab) & Signal Identification